China SXT Pharmaceuticals, Inc. (SXTC) stock
SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
$3.00+0.27 (+9.89%)
Close on Nov 13, 2026Market cap $2.87MP/E –Yield –
China SXT Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
China SXT Pharmaceuticals's enterprise value was -$25.25M on Nov 11, 2026, against $6.75T a year earlier. Over the last 5 years it ranged from -$25.25M to $52,633.12T, with a median of $13.55T.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$25.25M | -100.0% |
| 2025 | Dec 31, 2025 | $7.50T | +31397.4% |
| 2024 | Dec 31, 2024 | $23.80B | -99.9% |
| 2023 | Dec 29, 2023 | $27.73T | -94.1% |
| 2022 | Dec 30, 2022 | $469.73T | -99.1% |
| 2021 | Dec 31, 2021 | $52,633.12T | +859206.0% |
| 2020 | Dec 31, 2020 | $6.13T | +7.2% |
| 2019 | Dec 31, 2019 | $5.71T | – |
See a number that looks wrong?